Observational studyBreast cancer research and treatment2026
Real-world treatment patterns and outcomes in hormone receptor-positive, HER2-low metastatic breast cancer, 2018-2023: a retrospective, observational, US cohort study.
Erica L Mayer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.